Other languages Eris Lifesciences Limited

Equities

ERIS

INE406M01024

Delayed NSE India S.E. Other stock markets 07:40:29 2024-05-29 am EDT			5-day change	1st Jan Change
912.1 ^INR	+1.24%		+0.48%	+0.23%

May. 22	Eris Lifesciences Posts Gains in Fiscal Q4 Consolidated Net Profit	MT
May. 21	Eris Lifesciences Gets Board Nod to Raise Up to INR12.50 Billion Via Bond Sale	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Eris Lifesciences Posts Gains in Fiscal Q4 Consolidated Net Profit	May. 22
Eris Lifesciences Gets Board Nod to Raise Up to INR12.50 Billion Via Bond Sale	May. 21
Eris Lifesciences Completes Acquisition of Biocon Biologics' India Formulation Business	Apr. 02
Eris Lifesciences to Acquire India Formulation Business of Biocon Biologics for INR12.42 Billion	Mar. 15
Eris to Acquire Additional Stake in Swiss Parenterals, Take Over Branded Formulations Business of Biocon Biologics	Mar. 14
India's Biocon to sell branded formulations business to Eris Lifesciences for $150 million	Mar. 14
Eris Lifesciences Completes Purchase of 51% Stake in Swiss Parenterals	Feb. 15
Eris Lifesciences Limited completed the acquisition of 51% stake in Swiss Parenterals Limited.	Feb. 14
Eris Lifesciences Limited Provides Earnings Guidance for the Fiscal 2025 and Fiscal 2026	Feb. 13
Eris Lifesciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 13
India's Biocon posts profit on biosimilar boost, divestment gains; CFO resigns	Feb. 08
Eris Lifesciences Limited completed the acquisition of Dermatology and Nephrology branded formulations business units of Biocon Biologics	Nov. 09
Indian shares set to open higher tracking Asian peers	Nov. 08
Eris Lifesciences Limited Reaffirms Earnings Guidance for the Full Year of Fiscal 2024	Nov. 08
Eris Lifesciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 08
Eris Lifesciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-07
Eris Lifesciences Gains Dermatology Trademarks Acquired from Glenmark via Deal with Unit Eris Oaknet	23-07-03
Eris Lifesciences' Consolidated Profit Falls in Fiscal Q4	23-05-17
Eris Lifesciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-17
India's Glenmark Pharma weighs selling stake in Glenmark Life - Mint	23-04-11

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Eris Lifesciences Limited

Equities

ERIS

INE406M01024

Other languages

Filters